CAPR News

Capricor Therapeutics, Inc. CAPR Investors With Significant Losses Encouraged to Contact Kirby McInerney LLP About Securities Class Action

Faruqi & Faruqi, LLP Urges Capricor Therapeutics, Inc. (CAPR) Investors to Seek Counsel Before the September 28, 2026 Lead Plaintiff Deadline in the Securities Class Action Ready to Announce with Confidence?

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (CAPR)

CAPR Investor Reminder: Capricor Therapeutics Securities Fraud Class Action after 64% Stock Drop is Pending – Investors Notified to Contact BFA Law before September 28 Deadline

Securities Fraud Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) - Levi & Korsinsky Reminds Investors of September 28, 2026

SEPTEMBER 28, 2026 CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Levi & Korsinsky Urges Capricor Therapeutics, Inc. (CAPR) Shareholders to Act Before Lead Plaintiff Deadline September 28, 2026

Pomerantz LLP Reminds Shareholders with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit – CAPR

Contact Levi & Korsinsky by September 28, 2026 to Join Class Action Against Capricor Therapeutics, Inc. (CAPR)